About Cefepime Dosing

The Cefepime Renal Dose calculator provides guidance on adjusting intravenous (IV) cefepime dosages for adult patients based on their kidney function. Cefepime is a broad-spectrum, fourth-generation cephalosporin antibiotic used to treat moderate to severe infections. Because it is primarily eliminated by the kidneys, its dosage must be carefully modified in patients with renal impairment to prevent drug accumulation and potential toxicity.

Outputs Explained

The calculator provides the following key outputs for clinical consideration:

• Recommended Dose: The suggested amount of cefepime (e.g., 1g, 2g) for a single administration.
• Dosing Frequency: The recommended interval between doses (e.g., every 8 hours, every 12 hours, or every 24 hours).
• Calculated CrCl: An estimate of the patient’s creatinine clearance in mL/min, derived from the Cockcroft-Gault formula. This value is the primary determinant for dose adjustments.
• Rationale: A brief explanation of why the specific regimen was recommended, linking it to the patient’s calculated renal function and clinical indication.

How to Use This Information

To determine the appropriate dosing regimen, clinicians must assess the following patient parameters, which serve as inputs for the calculation:

• Patient Demographics: Age, weight, and biological sex are essential variables for the Cockcroft-Gault equation. This calculator is intended for adults only.
• Serum Creatinine (SCr): A recent lab value that reflects kidney function. It can be entered in either mg/dL or μmol/L.
• Clinical Indication: The severity of the infection (e.g., mild-to-moderate vs. severe/febrile neutropenia) influences the target dose and frequency.
• Renal Replacement Therapy (RRT): Dosing recommendations are significantly different for patients receiving intermittent hemodialysis (IHD) or continuous renal replacement therapy (CRRT).

Dosing Overview

Cefepime is used for serious infections such as hospital-acquired pneumonia, febrile neutropenia, complicated urinary tract infections, and intra-abdominal infections. For adults with normal renal function (CrCl > 60 mL/min), the standard dose is typically 2 grams IV every 8 to 12 hours. As renal function declines, the dosing interval is extended (e.g., from q8h to q12h or q24h) and/or the dose is reduced to prevent accumulation and minimize the risk of adverse events, particularly neurotoxicity.

Switching Therapy

Cefepime is an intravenous antibiotic for hospitalized patients. Decisions to switch therapy are based on clinical improvement, culture and sensitivity results, and the patient’s ability to tolerate oral medications. Antimicrobial stewardship principles encourage de-escalation to a narrower-spectrum antibiotic or a switch to an appropriate oral agent as soon as clinically feasible to complete the treatment course.

Missed Dose Protocol

In a hospital setting, medication administration is closely monitored. If a scheduled dose of cefepime is delayed or missed, it should be administered as soon as possible. The subsequent doses should then be rescheduled to maintain the correct dosing interval from the time the missed dose was given. Never administer two doses at once to “catch up.” Always follow institutional protocols and consult with the pharmacy or prescribing clinician for guidance.

Safety Alerts & Considerations

• Neurotoxicity: Cefepime is associated with a risk of neurotoxicity, including confusion, encephalopathy, myoclonus, and seizures. The risk is significantly higher in patients with renal impairment, especially if the dose is not appropriately adjusted. Monitor for any neurological changes.
• Hypersensitivity: Serious allergic reactions, including anaphylaxis, can occur. Cefepime is contraindicated in patients with a known history of severe hypersensitivity to cephalosporins, penicillins, or other beta-lactam antibiotics.
• Clostridioides difficile-Associated Diarrhea (CDAD): Like most broad-spectrum antibiotics, cefepime can alter gut flora and lead to an overgrowth of C. difficile, causing diarrhea that can range from mild to life-threatening colitis.
• Body Weight: The Cockcroft-Gault formula’s accuracy can be reduced in patients with extreme body weights. For obese patients, institutional guidelines may recommend using an adjusted or ideal body weight for a more accurate CrCl estimation.

Frequently Asked Questions

• Why is renal function so important for cefepime dosing?
  Cefepime is cleared almost entirely by the kidneys. If kidney function is poor, the drug can build up to toxic levels, increasing the risk of serious side effects like seizures.
• What is cefepime-induced neurotoxicity and who is at risk?
  It is a state of altered mental status, confusion, or seizures caused by high levels of cefepime in the brain. Patients with pre-existing renal impairment, the elderly, and those receiving inappropriately high doses are at the greatest risk.
• Does the calculator use ideal, adjusted, or actual body weight?
  The standard Cockcroft-Gault formula, as implemented in this calculator, uses the patient’s actual body weight. Clinicians should use their judgment and consult local protocols, as using adjusted body weight may be more appropriate for some obese patients.
• Can this calculator be used for pediatric patients?
  No. This tool is designed and validated for adult patients (over 18 years old) only. Pediatric dosing is complex and requires specialized references.
• How is cefepime dosed for patients on intermittent hemodialysis (IHD)?
  Patients on IHD typically receive a loading dose, followed by a smaller maintenance dose given once daily. On dialysis days, the dose should be administered after the session, as a significant portion of the drug is removed by dialysis.
• Why is dosing for Continuous Renal Replacement Therapy (CRRT) different?
  CRRT provides slow, continuous clearance of drugs, which differs from the rapid, intermittent clearance of IHD. Dosing on CRRT is often higher and more frequent than for IHD to maintain therapeutic drug levels, but can vary based on the CRRT modality and effluent rate.
• Is the Cockcroft-Gault formula always the best method to estimate renal function?
  While widely used for drug dosing, it has limitations, especially in patients with unstable renal function, or at extremes of age and muscle mass. Other equations like MDRD or CKD-EPI may be used for staging chronic kidney disease but are not typically validated for drug dosing adjustments.
• What are other common side effects of cefepime?
  Besides the major safety alerts, other potential side effects include rash, diarrhea, nausea, headache, and local reactions at the infusion site.

References

• U.S. Food and Drug Administration. Cefepime for Injection Prescribing Information. DailyMed.
• Payne LE, Gagnon DJ, et al. Cefepime-induced neurotoxicity: a systematic review. Crit Care. 2017;21(1):276.
• National Kidney Foundation. GFR Calculators & Cockcroft-Gault Equation.
• Lexicomp®. Cefepime: Drug Information. UpToDate, Inc. (Accessed via subscription).